Cargando…
Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
BACKGROUND: Direct-acting antiviral agents (DAAs) permit the use of interferon (IFN)-free regimens to treat hepatitis C (HCV) in patients with chronic kidney disease (CKD) on hemo-dialysis (HD) or renal transplant (RTx) recipients, with excellent response rates and safety. However, the occurrence of...
Autores principales: | Tavares, Rita Chelly Felix, de Castro Amaral Feldner, Ana Cristina, Pinho, João Renato Rebello, de Mello Malta, Fernanda, Carvalho-Filho, Roberto José, Santana, Rúbia Anita Ferraz, de Castro, Vanessa Fusco Duarte, Dastoli, Gregório Tadeu Fernando, Lima, Juliana Custódio, Ferraz, Maria Lucia Cardoso Gomes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208931/ https://www.ncbi.nlm.nih.gov/pubmed/30464541 http://dx.doi.org/10.2147/IDR.S169512 |
Ejemplares similares
-
Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis
por: Santos, Ana Paula de Torres, et al.
Publicado: (2022) -
Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil
por: de Torres Santos, Ana Paula, et al.
Publicado: (2021) -
Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up
por: Machado, Soraia Mafra, et al.
Publicado: (2017) -
Associations of SARS-CoV-2 cycle threshold values with age, gender, sample collection setting, and pandemic period
por: Franco-Miraglia, Fernando, et al.
Publicado: (2023) -
Long term persistence of coronavirus SARS-CoV-2 infection
por: Pinho, João Renato Rebello, et al.
Publicado: (2021)